Correlation Between Ford and NovaBay Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Ford and NovaBay Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ford and NovaBay Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ford Motor and NovaBay Pharmaceuticals, you can compare the effects of market volatilities on Ford and NovaBay Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ford with a short position of NovaBay Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ford and NovaBay Pharmaceuticals.
Diversification Opportunities for Ford and NovaBay Pharmaceuticals
-0.1 | Correlation Coefficient |
Good diversification
The 3 months correlation between Ford and NovaBay is -0.1. Overlapping area represents the amount of risk that can be diversified away by holding Ford Motor and NovaBay Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NovaBay Pharmaceuticals and Ford is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ford Motor are associated (or correlated) with NovaBay Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NovaBay Pharmaceuticals has no effect on the direction of Ford i.e., Ford and NovaBay Pharmaceuticals go up and down completely randomly.
Pair Corralation between Ford and NovaBay Pharmaceuticals
Taking into account the 90-day investment horizon Ford is expected to generate 13.53 times less return on investment than NovaBay Pharmaceuticals. But when comparing it to its historical volatility, Ford Motor is 2.35 times less risky than NovaBay Pharmaceuticals. It trades about 0.03 of its potential returns per unit of risk. NovaBay Pharmaceuticals is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest 57.00 in NovaBay Pharmaceuticals on August 25, 2024 and sell it today you would earn a total of 11.00 from holding NovaBay Pharmaceuticals or generate 19.3% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Ford Motor vs. NovaBay Pharmaceuticals
Performance |
| Timeline |
| Ford Motor |
| NovaBay Pharmaceuticals |
Ford and NovaBay Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Ford and NovaBay Pharmaceuticals
The main advantage of trading using opposite Ford and NovaBay Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ford position performs unexpectedly, NovaBay Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NovaBay Pharmaceuticals will offset losses from the drop in NovaBay Pharmaceuticals' long position.The idea behind Ford Motor and NovaBay Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| NovaBay Pharmaceuticals vs. Immix Biopharma | NovaBay Pharmaceuticals vs. Cns Pharmaceuticals | NovaBay Pharmaceuticals vs. Sonnet Biotherapeutics Holdings | NovaBay Pharmaceuticals vs. ZyVersa Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |